Pacgen Life Science Co. (PBS.V) Competitors

Pacgen Life Science Co. (PBS.V) (CVE:PBS) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Analyst Ratings

This is a summary of current ratings and recommmendations for Pacgen Life Science Co. (PBS.V) and BriaCell Therapeutics, as reported by MarketBeat.

Valuation and Earnings

This table compares Pacgen Life Science Co. (PBS.V) and BriaCell Therapeutics' gross revenue, earnings per share (EPS) and valuation.

BriaCell Therapeutics has lower revenue, but higher earnings than Pacgen Life Science Co. (PBS.V). Pacgen Life Science Co. (PBS.V) is trading at a lower price-to-earnings ratio than BriaCell Therapeutics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Pacgen Life Science Co. (PBS.V) and BriaCell Therapeutics' net margins, return on equity and return on assets.

Summary

Pacgen Life Science Co. (PBS.V) beats BriaCell Therapeutics on 2 of the 3 factors compared between the two stocks.

Pacgen Life Science Co. (PBS.V) (CVE:PBS) and Revive Therapeutics (CVE:RVV) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Valuation and Earnings

This table compares Pacgen Life Science Co. (PBS.V) and Revive Therapeutics' top-line revenue, earnings per share (EPS) and valuation.

Revive Therapeutics has lower revenue, but higher earnings than Pacgen Life Science Co. (PBS.V). Pacgen Life Science Co. (PBS.V) is trading at a lower price-to-earnings ratio than Revive Therapeutics, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations and price targets for Pacgen Life Science Co. (PBS.V) and Revive Therapeutics, as provided by MarketBeat.com.

Profitability

This table compares Pacgen Life Science Co. (PBS.V) and Revive Therapeutics' net margins, return on equity and return on assets.

Summary

Pacgen Life Science Co. (PBS.V) beats Revive Therapeutics on 2 of the 3 factors compared between the two stocks.

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) and Pacgen Life Science Co. (PBS.V) (CVE:PBS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, analyst recommendations, earnings and risk.

Profitability

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and Pacgen Life Science Co. (PBS.V)'s net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and Pacgen Life Science Co. (PBS.V)'s revenue, earnings per share and valuation.

Cotinga Pharmaceuticals Inc. (COT.V) has higher earnings, but lower revenue than Pacgen Life Science Co. (PBS.V). Pacgen Life Science Co. (PBS.V) is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and target prices for Cotinga Pharmaceuticals Inc. (COT.V) and Pacgen Life Science Co. (PBS.V), as reported by MarketBeat.

Dividends

Cotinga Pharmaceuticals Inc. (COT.V) pays an annual dividend of C$0.24 per share and has a dividend yield of 685.7%. Pacgen Life Science Co. (PBS.V) pays an annual dividend of C$0.09 per share and has a dividend yield of 300.0%. Cotinga Pharmaceuticals Inc. (COT.V) pays out -208.7% of its earnings in the form of a dividend. Pacgen Life Science Co. (PBS.V) pays out -1,500.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Pacgen Life Science Co. (PBS.V) beats Cotinga Pharmaceuticals Inc. (COT.V) on 3 of the 5 factors compared between the two stocks.

Medifocus Inc. (MFS.V) (CVE:MFS) and Pacgen Life Science Co. (PBS.V) (CVE:PBS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Profitability

This table compares Medifocus Inc. (MFS.V) and Pacgen Life Science Co. (PBS.V)'s net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Medifocus Inc. (MFS.V) and Pacgen Life Science Co. (PBS.V)'s revenue, earnings per share and valuation.

Pacgen Life Science Co. (PBS.V) has lower revenue, but higher earnings than Medifocus Inc. (MFS.V). Pacgen Life Science Co. (PBS.V) is trading at a lower price-to-earnings ratio than Medifocus Inc. (MFS.V), indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and price targets for Medifocus Inc. (MFS.V) and Pacgen Life Science Co. (PBS.V), as provided by MarketBeat.

Summary

Pacgen Life Science Co. (PBS.V) beats Medifocus Inc. (MFS.V) on 3 of the 5 factors compared between the two stocks.

(CHV) (CNSX:CHV) and Pacgen Life Science Co. (PBS.V) (CVE:PBS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership.

Profitability

This table compares (CHV) and Pacgen Life Science Co. (PBS.V)'s net margins, return on equity and return on assets.

Valuation & Earnings

This table compares (CHV) and Pacgen Life Science Co. (PBS.V)'s gross revenue, earnings per share and valuation.

(CHV) has higher earnings, but lower revenue than Pacgen Life Science Co. (PBS.V).

Analyst Ratings

This is a summary of recent recommendations and price targets for (CHV) and Pacgen Life Science Co. (PBS.V), as reported by MarketBeat.

Summary

Pacgen Life Science Co. (PBS.V) beats (CHV) on 1 of the 1 factors compared between the two stocks.

(PREV) (CNSX:PREV) and Pacgen Life Science Co. (PBS.V) (CVE:PBS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for (PREV) and Pacgen Life Science Co. (PBS.V), as reported by MarketBeat.

Valuation and Earnings

This table compares (PREV) and Pacgen Life Science Co. (PBS.V)'s gross revenue, earnings per share (EPS) and valuation.

(PREV) has higher earnings, but lower revenue than Pacgen Life Science Co. (PBS.V).

Profitability

This table compares (PREV) and Pacgen Life Science Co. (PBS.V)'s net margins, return on equity and return on assets.

Summary

Pacgen Life Science Co. (PBS.V) beats (PREV) on 1 of the 1 factors compared between the two stocks.